C. Kosti

Predictors of Mortality in Tocilizumab-Treated Severe COVID-19

I. Papanikolaou, Eleftherios Markatis, K. Dimakou, 2022, Vaccines.

CSF1/CSF1R Axis Blockade Limits Mesothelioma and Enhances Efficiency of Anti-PDL1 Immunotherapy

I. Kalomenidis, K. Psarra, S. Magkouta, 2021, Cancers.

CSF1/CSF1R signaling mediates malignant pleural effusion formation

I. Kalomenidis, K. Psarra, S. Magkouta, 2022, JCI insight.

MTH1 favors mesothelioma progression and mediates paracrine rescue of bystander endothelium from oxidative damage.

V. Gorgoulis, I. Kalomenidis, C. Moschos, 2020, JCI insight.

MTH1 Inhibition Alleviates Immune Suppression and Enhances the Efficacy of Anti-PD-L1 Immunotherapy in Experimental Mesothelioma

K. Psarra, M. Iliopoulou, C. Kosti, 2023, Cancers.